Podcasts

Episode 8 | Practical Perspectives: Shifting the Needle in Small Cell Lung Cancer

Practical Perspectives: Shifting the Needle in Small Cell Lung Cancer (SCLC)

Episode Summary

This TOGA Podcast focuses on Small Cell Lung cancer (SCLC) – a type of lung cancer with the poorest prognosis of any lung cancer. Our guests today include A/Prof Steven Kao, A/Prof Stephen Liu, and Dr Rebecca Tay. SCLC patients make up about 13% of new lung cancer diagnoses that are characterized by early & rapid spread with only modest progress in its treatment over the last decades. Immunotherapy continues to radically change the way we treat many types of lung cancer and today we explore what these treatments mean for the SCLC patient and the practical implications of using immunotherapies in the clinic. We also discuss future combinations and novel agents in clinical trial development.

 

Thank you for joining us and also thank you to Roche for sponsoring this Podcast.

 

Useful link: https://www.frontiersin.org/articles/10.3389/fonc.2020.01074/full

 

Disclaimer: The opinions, beliefs and viewpoints expressed by the various authors and participants contained in this message do not necessarily reflect the opinions, beliefs and viewpoints of TOGA or official policies of TOGA. Dosage & administration of any treatments mentioned during TOGA medical education may differ between Regions. Please refer to your local prescribing information for further details.

Show Hosts

This episode’s host are:

  • A/Prof Steven Kao, Medical Oncologist, Chris O’Brien Lifehouse
  • A/Prof Stephen Liu, Director of Thoracic Oncology and Director of Developmental Therapeutics, Lombardi Comprehensive Cancer Centre Georgetown University
  • Dr Rebecca Tay, Medical Oncologist, Royal Hobart Hospital and Icon Cancer Centre

Play Episode 8 | Practical Perspectives: Shifting the Needle in Small Cell Lung Cancer

More Podcasts

A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.